PPCB did a 1-for-10 reverse split on Oct 26, 2026. Fund positions use its last close before the split, $0.2800 on Oct 23, 2026, until the new shares are matched.
PPCB institutional ownership changes in Q1 2026: 4 institutions opened or added positions, 3 trimmed or exited. PPCB (Propanc Biopharma, Inc.) is held by 5 institutional investors as of Q1 2026. Top institutional shareholders: UBS Group AG ($19,357), Jane Street Group, LLC ($15,180), Marex Group Ltd ($7,179). Net institutional sentiment: Mixed.
Who's Trading
Source dates: Price Oct 23, 2026 · Insiders none · Activists none · Congress none
No recent insider, activist, or congressional trades for PPCB.
Top Holders
| Action | ||||||
|---|---|---|---|---|---|---|
New | 182,614 | $19,357 | 0.0% | -89.43% | 28 | |
New | 143,212 | $15,180 | 0.0% | -89.43% | 28 | |
Increased | 67,724(+4.2%) | $7,179 | 0.0% | -99.32% | 11 | |
New | 40,748 | $4,000 | 0.0% | -89.43% | 20 | |
Decreased | 12,098(-45.3%) | $1,282 | 0.0% | -97.91% | 0 | |
Exited | 0(-100.0%) | $8,724 | 0.0% | -80.25% | 0 | |
Exited | 0(-100.0%) | $1 | 0.0% | -93.76% | 0 |
PPCBPropanc Biopharma, Inc.Continue exploring
Questions investors ask about PPCB
Who owns PPCB?
5 institutional investors held PPCB on March 31, 2026, led by UBS Group AG ($19,357), Jane Street Group, LLC ($15,180) and Marex Group Ltd ($7,179).
How many hedge funds hold PPCB?
5 institutional investors reported PPCB in their 13F filings for the quarter ended March 31, 2026, $46,998 in all.
Are institutions buying or selling PPCB?
Buying, on balance. In Q1 2026, 4 institutions opened or added to positions in PPCB and 3 institutions trimmed or exited.
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer